Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant

• Main Authors: Pil Soo Sung (Author), Ji Won Han (Author), Changho Seo (Author), Joseph Ahn (Author), Soon Kyu Lee (Author), Hee Chul Nam (Author), Ho Joong Choi (Author), Young Kyoung You (Author), Jeong Won Jang (Author), Jong Young Choi (Author), Seung Kew Yoon (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Mammalian target of rapamycin (mTOR) inhibitors, such as everolimus and sirolimus, may be efficacious in preserving renal function in liver transplantation (LT) recipients while preventing hepatocellular carcinoma (HCC) recurrence.Materials and Methods: In this study, we retrospectively...